# Tucumán medical research and public health surveillance

> Live situation record from CLSTR: https://clstr.news/situations/tucumn-medical-research-and-public-health-surveillance
> Updated: 2026-10-04T09:56:51.000Z. Sources: 4. Developments: 2.

Tucumán has developed into an international center for vaccine research through long-term collaboration between public hospitals, private laboratories, and the Mayo Clinic. A significant achievement includes a global clinical trial for a respiratory syncytial virus (RSV) vaccine, where the Maternidad de Tucumán served as the leading global center for enrolling pregnant patients. This research contributed to Argentina incorporating the vaccine into its national immunization schedule in 2024.

In addition to research, the Tucumán Ministry of Public Health has strengthened epidemiological surveillance to monitor transmissible diseases. While local conditions for dengue and chikungunya remain favorable, health officials have expressed concern regarding the international circulation of measles in countries like the United States, Canada, and Peru, warning of potential importation risks through travel.

## Timeline

### 2026-10-04: Tucumán advances vaccine research and epidemiological surveillance

Tucumán is a global leader in vaccine research, notably in RSV trials, while local health officials increase surveillance for measles due to rising international cases.

3 sources. https://clstr.news/cluster/tucumn-advances-vaccine-research-and-epidemiological-surveillance

### 2026-09-28: Tucumán leads Argentine provinces in employment growth

Tucumán led Argentine provinces in employment growth with an 8.3% increase over the last three years, driven by public works and coordination between the state and private sectors.

2 sources. https://clstr.news/cluster/tucumn-leads-argentine-provinces-in-employment-growth

---
Cite as: Tucumán medical research and public health surveillance. CLSTR, https://clstr.news/situations/tucumn-medical-research-and-public-health-surveillance